Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Melanoma × ganitumab × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Neoplasm Metastasis 4 Colorectal Neoplasms 4 Sarcoma 3 Sarcoma, Ewing 2 Insulin-Like Growth Factor I, Resistance To 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoid Tumor 2 Breast Neoplasms 2 Small Cell Lung Carcinoma 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Rhabdomyosarcoma 1 Recurrence 1 Rectal Neoplasms 1 Pleural Effusion, Malignant 1 Neuroendocrine Tumors 1 Neoplasms 1 Lymphoma 1 Lung Neoplasms 1 Jaundice 1 Gastrointestinal Neoplasms 1 Endocrine Gland Neoplasms 1 Colonic Neoplasms 1 Adenoma, Islet Cell 1 Adenocarcinoma 1

Interventions

Ipilimumab 96 pembrolizumab 81 Nivolumab 79 aldesleukin 51 Cyclophosphamide 49 Interleukin-2 38 fludarabine phosphate 31 Vemurafenib 31 Dacarbazine 31 dabrafenib 29 trametinib 28 Temozolomide 26 fludarabine 25 CTLA-4 Antigen 18 Bevacizumab 18 Radiosurgery 15 Paclitaxel 15 Carboplatin 14 encorafenib 13 binimetinib 13 Introns 13 talimogene laherparepvec 12 Interferon alpha-2 12 spartalizumab 10 cobimetinib 10 atezolizumab 10 Radiotherapy 10 sargramostim 9 peginterferon alfa-2b 9 montanide ISA 51 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡